TP53 and kidney neoplasm: To determine whether paediatric kidney tumour organoids can be genetically manipulated, we set out to model anaplastic Wilms tumours by generating TP53-knockout mutations in TP53-wild-type Wilms tumour organoids using CRISPR/Cas9 gene editing.